FirmaIQ
Org.nr 979 455 518 AS · LEKNES · 72.100 Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk Lofoten Bio Centre, Storeidøya 60, 8370 LEKNES Latest filing: Årsregnskap 2025 · approved 30.06.2026 · journal 2026 725727 Analysis generated: 22 Aug 2026 · Auto-onboard

ACD PHARMACEUTICALS AS

ACD PHARMACEUTICALS AS · 29 published annual accounts (1997–2025). Latest year revenue 25.6m NOK, net result -1.9m NOK, equity 55.7m NOK, cash 41.8m NOK. Figures from Brønnøysund årsregnskapskopi / nøkkeltall.

Auto summary · grounded in R1997–R2025
Reported fact Calculated Interpretation Unknown

Smart Search OSINT dossier

Simple version

Explain it like I’m ten

Numbers from the 2025 accounts. [R2025]

How much they sold
About 25.6m

Operating income / revenue in 2025.

Did they make money?
-1.9m

Net result for 2025.

What’s left in the company
Equity 55.7m

Book equity at year-end.

Cash
41.8m

Bank deposits and cash (when disclosed).

At a glance · 2025

Key figures

Revenue / sales
25 629 459
NOK · [R2025]
Net result
-1 922 210
NOK · [R2025]
Equity
55 721 271
NOK · [R2025]
Cash
41 759 659
NOK · [R2025]
Total assets
120 997 253
NOK · [R2025]
Paid-in equity
55 721 271
NOK · [R2025]

Trends

29-year arc

Charts use figures extracted from published annual reports.

Sales / revenue

Equity & cash

Cost / investment lines

Salary costs (lønnskostnader)

FTEs (årsverk)

From notes when disclosed; blank years mean not found in OCR.